Form 8-K - Current report:
SEC Accession No. 0001140361-24-048907
Filing Date
2024-12-10
Accepted
2024-12-10 16:05:17
Documents
18
Period of Report
2024-12-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20039836_8k.htm   iXBRL 8-K 28343
2 EXHIBIT 99.1 ef20039836_ex99-1.htm EX-99.1 27495
6 image00001.jpg GRAPHIC 2203
7 image00002.jpg GRAPHIC 2624
8 image00003.jpg GRAPHIC 5888
9 image00004.jpg GRAPHIC 4814
  Complete submission text file 0001140361-24-048907.txt   220907

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA siga-20241210.xsd EX-101.SCH 3971
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE siga-20241210_lab.xml EX-101.LAB 21967
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE siga-20241210_pre.xml EX-101.PRE 16037
20 EXTRACTED XBRL INSTANCE DOCUMENT ef20039836_8k_htm.xml XML 4052
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Filer) CIK: 0001010086 (see all company filings)

IRS No.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38436 | Film No.: 241538480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)